Treace Medical Concepts, Inc. Common Stock (TMCI) Stock Price

TMCIStock

$3.87−39.34%52W

Market Cap$251.68M

P/E—

PEG Ratio—

Div yield—

Beta1.58

TMCI Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)71.78%

Price vs S&P 500 (4W)-12.29%

VGM Score52.59

Book Value / Share (Quarterly)$1.04

P/TBV (Annual)1.95x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)14.47%

Cash Flow / Share (Quarterly)$-0.39

Price vs S&P 500 (YTD)46.03%

Gross Margin (TTM)79.45%

Net Profit Margin (TTM)-28.99%

EPS (TTM)$-0.93

10-Day Avg Trading Volume0.24M

EPS Excl Extra (TTM)$-0.93

Revenue Growth (5Y)29.95%

EPS (Annual)$-0.93

ROI (Annual)-41.28%

Gross Margin (Annual)79.81%

Net Profit Margin (5Y Avg)-26.57%

Cash / Share (Quarterly)$0.70

Revenue Growth QoQ (YoY)-4.24%

ROA (Last FY)-30.96%

Revenue Growth TTM (YoY)-3.95%

EBITD / Share (TTM)$-0.75

ROE (5Y Avg)-49.14%

Operating Margin (TTM)-27.50%

Cash Flow / Share (Annual)$-0.46

P/B Ratio3.72x

P/B Ratio (Quarterly)3.81x

Net Income / Employee (Annual)$-131,100

EV / Revenue (TTM)1.45x

Net Interest Coverage (TTM)-22.20x

ROA (TTM)-31.64%

EPS Incl Extra (Annual)$-0.93

Current Ratio (Annual)4.31x

Quick Ratio (Quarterly)1.79x

3-Month Avg Trading Volume0.51M

52-Week Price Return-39.34%

Revenue / Employee (TTM)$456,200

Tangible BV / Share (Quarterly)$0.94

P/S Ratio (Annual)1.18x

Asset Turnover (Annual)1.12x

52-Week High$7.08

Operating Margin (5Y Avg)-25.25%

EPS Excl Extra (Annual)$-0.93

CapEx CAGR (5Y)66.07%

26-Week Price Return81.69%

Quick Ratio (Annual)2.95x

13-Week Price Return-10.00%

Total Debt / Equity (Annual)0.64x

Current Ratio (Quarterly)2.90x

Enterprise Value$298.28M

Revenue / Share Growth (5Y)24.22%

Asset Turnover (TTM)1.09x

Revenue / Employee (Annual)$472,600

Inventory Turnover (Annual)1.14x

Pretax Margin (Annual)-27.74%

Cash / Share (Annual)$0.76

3-Month Return Std Dev59.88%

Gross Margin (5Y Avg)80.63%

Net Income / Employee (TTM)$-132,300

ROE (Last FY)-67.56%

Net Interest Coverage (Annual)-15.03x

EPS Basic Excl Extra (Annual)$-0.93

Receivables Turnover (TTM)6.95x

Total Debt / Equity (Quarterly)0.87x

EPS Incl Extra (TTM)$-0.93

Receivables Turnover (Annual)5.13x

ROI (TTM)-43.49%

P/S Ratio (TTM)1.23x

Pretax Margin (5Y Avg)-26.57%

Revenue / Share (Annual)$3.36

Tangible BV / Share (Annual)$1.25

Price vs S&P 500 (52W)-54.87%

Year-to-Date Return57.96%

5-Day Price Return-5.61%

EPS Normalized (Annual)$-0.93

ROA (5Y Avg)-23.57%

Net Profit Margin (Annual)-27.74%

Month-to-Date Return-12.84%

Cash Flow / Share (TTM)$-0.73

EBITD / Share (Annual)$-0.73

Operating Margin (Annual)-26.75%

LT Debt / Equity (Annual)0.64x

ROI (5Y Avg)-31.08%

LT Debt / Equity (Quarterly)0.83x

EPS Basic Excl Extra (TTM)$-0.93

P/TBV (Quarterly)4.23x

P/B Ratio (Annual)1.79x

Inventory Turnover (TTM)1.03x

Pretax Margin (TTM)-28.99%

Book Value / Share (Annual)$1.36

Price vs S&P 500 (13W)-12.69%

Beta1.58x

Revenue / Share (TTM)$3.16

ROE (TTM)-74.06%

52-Week Low$1.17

vGradeB

gGradeC

mGradeC

vgmGradeC

TMCI Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 7, 2026	-$0.30	-$0.20	+33.30%(+$0.10)
Q1 2026	May 8, 2026	-$0.31	-$0.12	+62.78%(+$0.19)
Q4 2025	Feb 27, 2026	-$0.14	-$0.08	+44.07%(+$0.06)
Q3 2025	Nov 6, 2025	-$0.27	-$0.22	+18.17%(+$0.05)
Q2 2025	Aug 7, 2025	-$0.29	-$0.26	+9.79%(+$0.03)

TMCI Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

2.50

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
TMCITreace Medical Concepts, Inc. Common Stock	B	C	C	1.2x	29.9%	79.5%	-27.5%	$3.87
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24

About Treace Medical Concepts, Inc. Common Stock

Treace Medical Concepts develops and commercializes the Lapiplasty 3D Bunion Correction procedure, a patented surgical solution for treating bunion deformities. The procedure addresses the underlying cause of bunions across all planes of deformity while enabling patients to return to normal activities quickly. The company markets its devices to surgeons, ambulatory surgery centers, and hospitals in the large and growing orthopedic foot surgery market.

TMCI Next Earnings Report

Report dateNov 5, 2026

QuarterQ3 2026

Report timeBMO

EPS estimate-$0.25

Revenue estimate$47.71M

Also reporting on Nov 5, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

TMCI Insider Transactions

BuyAug 24, 2026
TREACE JOHN T.
Chief Executive Officer
Shares: 55,944Value: $246,654

Open-market buys and sells filed with the SEC over the last 90 days. Grants, gifts and option exercises are excluded.

All insider transactions for August 2026

Companies in Related Industries

SMTISanara MedTech Inc. Common StockOrthopedic & Prosthetic Devices
OPTXSyntec Optics Holdings, Inc. Class A Common StockOptical Instruments & Lenses
NAUTNautilus Biotechnolgy, Inc. Common StockLab Analytical Instruments
EYPTEyePoint, Inc. Common StockLab Analytical Instruments
QSIQuantum-Si Incorporated Class A Common StockMeasuring & Controlling Devices
ELMDElectromed, Inc.Electromedical Equipment
GPROGoPro, Inc.Photographic Equipment & Supplies
FOCLEDAP TMS S.A. American Depositary SharesElectromedical Equipment

Same SIC sector, outside this company's own industry.

Analyst Sentiment

2.5

Sell

Consensus rating

52-Week Range

Low$1.17

High$7.08